MetLife Investment Management’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

MetLife Investment Management’s Portfolio LBPH Stock Details LBPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-18,980	Closed	-$633K	–	2897
2024 Q3	$633K	Hold	18,980	–	–	﹤0.01%	1655
2024 Q2	$513K	Buy	18,980 +5,784	+44%	+$114K	﹤0.01%	1706
2024 Q1	$285K	Buy	+13,196	New	+$288K	﹤0.01%	1984
2023 Q3	–	Sell	-8,932	Closed	-$65.6K	–	3033
2023 Q2	$65.6K	Buy	+8,932	New	+$67.6K	﹤0.01%	2865

MetLife Investment Management's LBPH Position: Q4 2024 in Review

MetLife Investment Management sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q4 2024, closing a stake of 18,980 shares — an estimated $633K sold.

MetLife Investment Management first reported a position in LBPH in Q2 2023 and held it in 4 quarters. The position peaked at $633K in Q3 2024. 0 funds tracked by Wall St. Rank hold LBPH as of Q4 2024.

MetLife Investment Management reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
MetLife Investment Management sold 18,980 Longboard Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $633K.
MetLife Investment Management first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q2 2023 and held it in 4 quarters.
MetLife Investment Management's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $633K in Q3 2024.
0 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q4 2024.

Based on MetLife Investment Management's 13F filing for Q4 2024, filed 13 Feb 2025.